IP Library Granted Patent US 6,856,835
Granted Patent B2
US 6,856,835 · App. 09/940,266 · Granted Feb 15, 2005

Biphasic waveform for anti-tachycardia pacing for a subcutaneous implantable cardioverter-defibrillator

Assignee: Cameron Health, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,856,835
App. No.
09/940,266
Granted
Feb 15, 2005
Kind
B2
Abstract

A power supply for an implantable cardioverter-defibrillator for subcutaneous positioning between the third rib and the twelfth rib and using a lead system that does not directly contact a patient's heart or reside in the intrathorasic blood vessels and for providing anti-tachycardia pacing energy to the heart, comprising a capacitor subsystem for storing the anti-tachycardia pacing energy for delivery to the patient's heart; and a battery subsystem electrically coupled to the capacitor subsystem for providing the anti-tachycardia pacing energy to the capacitor subsystem.

Claims (53)

1. A method of treating an abnormal cardiac rhythm comprising:

providing an implantable stimulus device in a patient, the implantable stimulus device including a power source and an energy storage system;

providing a lead system for the stimulus device, the step of providing the lead system including a process resulting in implantation of the leads only to areas that are exclusive of the patient's heart;

sensing an event in the patient's cardiac rhythm;

coupling the power source to the energy storage system to transfer energy to the energy storage system;

storing energy in the energy storage system; and

discharging the energy from the energy storage system using the lead system to a subcutaneous volume of the patient;

wherein the lead system includes a first electrode and the implantable stimulus device includes a second electrode on a housing thereof, wherein the steps of providing the stimulus device and providing the lead assembly are performed such that a straight line drawn from the first electrode to the second electrode would intersect a portion of the heart, and the step of discharging energy from the energy storage system includes discharging energy between the first electrode and the second electrode.

2. The method of claim 1 , wherein the step of sensing an event in the patient's cardiac rhythm is performed in order to detect an abnormally fast heart rhythm.

3. The method of claim 2 , wherein:

the steps of storing energy and discharging the energy are repeated at an initial rate set to overdrive the abnormally fast heart rhythm until the heart is captured for pacing purposes; and, then,

a rate at which the steps of storing energy and discharging energy are performed is reduced.

4. The method of claim 3 , wherein the initial rate is in the range of 100 to 300 stimuli per minute.

5. The method of claim 1 , wherein the step of providing an implantable stimulus device includes implanting the stimulus device subcutaneously between approximately the third rib and the twelfth rib of the patient.

6. The method of claim 1 , wherein the step of providing an implantable stimulus device includes implanting the stimulus device at about the left axillary line with the lead system including a lead extending medially therefrom.

7. The method of claim 1 , wherein the step of providing an implantable stimulus device includes placing the stimulus device at a subcutaneous location along the inframammary crease of the patient.

8. The method of claim 1 , wherein the step of discharging the energy is performed to produce a biphasic waveform.

9. A method of treating an abnormal cardiac rhythm comprising:

providing an implantable stimulus device in a patient, the implantable stimulus device including a power source and an energy storage system;

providing a lead system for the stimulus device, the step of providing the lead system including a process resulting in implantation of the leads only to areas that are exclusive of the patient's heart;

sensing an event in the patient's cardiac rhythm;

coupling the power source to the energy storage system to transfer energy to the energy storage system;

storing energy in the energy storage system; and

discharging the energy from the energy storage system using the lead system to a subcutaneous volume of the patient;

wherein the step of providing an implantable stimulus device includes implanting the stimulus device at about the left axillary line with the lead system including a lead extending medially therefrom.

10. A method of treating an abnormal cardiac rhythm comprising:

providing an implantable stimulus device in a patient, the implantable stimulus device including a power source and an energy storage system;

providing a lead system for the stimulus device, the step of providing the lead system including a process resulting in implantation of the leads only to areas that are exclusive of the patient's heart;

sensing an event in the patient's cardiac rhythm;

coupling the power source to the energy storage system to transfer energy to the energy storage system;

storing energy in the energy storage system; and

discharging the energy from the energy storage system using the lead system to a subcutaneous volume of the patient;

wherein the step of providing an implantable stimulus device includes placing the stimulus device at a subcutaneous location along the inframammary crease of the patient.

11. A method of treating tachycardia comprising:

providing an implantable stimulus device subcutaneously in a patient to a location at approximately the left anterior axillary line of the patient between the third and the twelfth ribs, the implantable stimulus device including a power source and an energy storage system;

providing a lead system for the stimulus device by passing the lead system to locations exclusive of the patient's heart;

sensing events in the patient's cardiac rhythm to determine whether an abnormally fast heart rhythm is occurring; and if so, repeating the following steps at an initial rate to overdrive the abnormally fast heart rhythm:

coupling the power source to the energy storage system to transfer energy to the energy storage system;

storing energy in the energy storage system; and

discharging the energy from the energy storage system via first and second electrodes disposed within the patient exclusive of the patient's heart, in a biphasic waveform;

and then repeating the steps at a reduced rate.

12. The method of claim 11 , wherein both the first and second electrodes are part of the lead system.

13. The method of claim 11 , wherein the first electrode is part of the lead system and the second electrode is disposed on a housing for the implantable cardioverter-defibrillator.

14. A method of treating an abnormal cardiac rhythm comprising:

providing an implantable stimulus device in a patient, the implantable stimulus device including a power source and an energy storage system;

providing a lead system for the stimulus device, the step of providing the lead system including a process resulting in implantation of the leads only to areas that are exclusive of the patient's heart;

sensing an event in the patient's cardiac rhythm;

coupling the power source to the energy storage system to transfer energy to the energy storage system;

storing energy in the energy storage system; and

discharging the energy from the energy storage system using the lead system to a subcutaneous volume of the patient; wherein:

the step of sensing an event in the patient's cardiac rhythm is performed in order to detect an abnormally fast heart rhythm; and

the steps of storing energy arid discharging the energy are repeated at an Initial rate set to overdrive the abnormally fast heart rhythm until the heart is captured for pacing purposes and, then, a rate at which the steps of storing energy and discharging energy are performed is reduced.

15. The method of claim 14 , wherein the lead system includes a first electrode and the implantable stimulus device includes a second electrode on a housing thereof, wherein the steps of providing the stimulus device and providing the lead assembly are performed such that a straight line drawn from the first electrode to the second electrode would intersect a portion of the heart, and the step of discharging energy from the energy storage system includes discharging energy between the first electrode and the second electrode.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2008
From: COMERICA BANK
To: CAMERON HEALTH INC.
Reel/Frame 020758/0413 →
SECURITY INTEREST Recorded Mar 13, 2003
From: CAMERON HEALTH, INC.
To: COMERICA BANK-CALIFORNIA
Reel/Frame 013848/0266 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2001
From: BARDY, GUST H.; CAPPATO, RICCARDO; RISSMANN, WILLIAM J.
To: CAMERON HEALTH, INC.
Reel/Frame 012330/0215 →
Continuity (3)
Continuation In Part 0966360700 · Sep 18, 2000
Continuation In Part 0966360600 · Sep 18, 2000
Related Publication 20020035376A1 · Mar 21, 2002